Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
North Atlantic Smaller Companies Investment Trust Plc LSE:NAS London Ordinary Share GB0006439003 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 3,920.00 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
3,900.00 3,940.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 12.35 5.87 41.24 95.1 565
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 3,920.00 GBX

North Atlantic Smaller C... (NAS) Latest News

More North Atlantic Smaller C... News
North Atlantic Smaller C... Investors    North Atlantic Smaller C... Takeover Rumours

North Atlantic Smaller C... (NAS) Discussions and Chat

North Atlantic Smaller C... Forums and Chat

Date Time Title Posts
25/1/202116:59North Atlantic Smaller Companies IT215
04/1/201020:23Nasdaq Swing Traders34
17/1/200820:57Nasdaq charts etc7
02/11/200606:491420 Broken on NAS - Tech recovery???2
25/5/200609:33Was this the bottom, it's flying now3

Add a New Thread

North Atlantic Smaller C... (NAS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-03-04 17:03:263,875.903,445133,524.76O
2021-03-04 16:59:493,859.61772,971.90O
2021-03-04 16:29:403,920.002469,643.20O
2021-03-04 16:28:573,920.002469,643.20AT
2021-03-04 16:28:503,920.00278.40AT
View all North Atlantic Smaller C... trades in real-time

North Atlantic Smaller C... (NAS) Top Chat Posts

DateSubject
04/3/2021
08:20
North Atlantic Smaller C... Daily Update: North Atlantic Smaller Companies Investment Trust Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker NAS. The last closing price for North Atlantic Smaller C... was 3,920p.
North Atlantic Smaller Companies Investment Trust Plc has a 4 week average price of 3,830p and a 12 week average price of 3,260p.
The 1 year high share price is 4,050p while the 1 year low share price is currently 2,200p.
There are currently 14,425,620 shares in issue and the average daily traded volume is 15,015 shares. The market capitalisation of North Atlantic Smaller Companies Investment Trust Plc is £565,484,304.
25/1/2021
16:59
davebowler: 18 January 2021 NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC The Board announces that as at 31 December 2020 the unaudited net asset value per share (excluding current period revenue) under the equity accounting method was 5,077.43p.
04/1/2021
13:10
davebowler: The Board announces that as at 30 November 2020 the unaudited net asset value per share (excluding current period revenue) under the equity accounting method was 4,743.88p. The unaudited net asset value per share quoted above differs from that required under IFRS 10, which was adopted by the Company from 1 February 2014 as detailed in its Half Yearly Financial Report for the six months ended 31 July 2014. The unaudited net asset value per share (excluding current period revenue) under IFRS 10 was 4,646.62p
16/12/2020
15:24
davebowler: The Board announces that as at 31 October 2020 the unaudited net asset value per share (excluding current period revenue) under the equity accounting method was 4,429.62p. The unaudited net asset value per share quoted above differs from that required under IFRS 10, which was adopted by the Company from 1 February 2014 as detailed in its Half Yearly Financial Report for the six months ended 31 July 2014. The unaudited net asset value per share (excluding current period revenue) under IFRS 10 was 4,347.01p.
04/12/2020
14:40
spartacus mills: Nice bounce towards £34 - looks like the news is out about the Telos IPO. Also some shares bought back today at £33.75. Mills typically has a good view of what his own shares are worth - so notable that this is the highest price he has yet paid for a buy back. Shares seemed to have been sourced from Capital Gearing who remain big holders. An optimistic scenario says the next NAV could be close to £50 and assuming a Brexit deal a 20% discount seems appropriate for well run but illiquid UK small cap portfolio with high fees. So giving a target over the next month or two of £40 or so
27/11/2020
17:08
spartacus mills: Worth a listen to this podcast in which Chris Mills gives a decent tour of the current NAS and OIG portfolio. hxxps://www.voxmarkets.co.uk/media/5fb3dd97bc74c922485f4f5b/?context=/series/daily-podcast/ Intriguingly at 39:45 he mentions a US cyber security company which NAS has a stake in which is due to go public. He sees an uplift from £3m to £24m in the value of the stake! Looking the most recent Annual report this looks like Telos which lo-and-behold has gone public and popped 20% on it’s opening day Nov 18th Suggests a tasty 3%+ uplift to the next NAV announcement!
27/10/2020
21:41
rambutan2: Lists on thurs, with NAS holding a good chunk: hTtps://sourcebiointernational.com/aim-rule-26/ https://investegate.co.uk/sourcebio-intl-plc/rns/placing-and-proposed-admission-to-trading-on-aim/202010270700092589D/
27/10/2020
20:06
topvest: The performance is very good. NAS has nearly tripled in a decade and Oryx has done even better. NAV performance is a c10-12% per annum compounder. I'm not greedy and invest in things that have a strong chance of doing 10%+ a year which is my minimum hurdle. I'm not really interested in things that can't make 10% per annum long term. I've always felt that NAS is better / certainly safer than Oryx. Oryx has out-performed of late as is more fully invested whereas NAS is more prudently positioned for the nightmare economic scenario we are now facing. It does mean that NAS has significant firepower when the value is there for some good deals. NAS also owns a significant % of Oryx. Odyssean are also part owned by NAS and if the manager doesn't perform to his high expectations, I expect Christopher Mills to muscle in on this one as well at an opportune time! From a few years ago: "Christopher became the Investment Manager for what was then Montagu Boston in 1982 and he became our Chief Executive in 1984. Since then the net asset value is up over one hundred times." Obviously when / if Christopher Mills retires then the investment trust may get liquidated and then the discount would likely go as well, but would lead to some short-term uncertainty no doubt. There is some risk on this front I guess!
17/9/2020
05:20
p1nkfish: No way to know, a very cryptic mention and a bit of a tease. I think NAS is raising whatever cash it can via taking advantage now ready for something. Perhaps an anticipated big turn down or changes to landscape post Brexit. Some bargains will be thrown up.
16/9/2020
19:49
rambutan2: Interims out: chief executive's review During the six month period under review the fully diluted net asset value fell by 9.7% (with Oryx under the equity method of accounting) as compared to a rise in the Sterling adjusted Standard & Poors Composite Index of 2.4%. The performance however compares very favourably with appropriate UK indices. The Company incurred a loss for the period of GBP629,000 (31 July 2019: profit of GBP3,671,000) as dividends were slashed in the UK and interest income on US Treasuries fell to almost nothing. The Company did not purchase any ordinary shares for cancellation during the period. quoted portfolio The COVID pandemic materially impacted a significant part of the quoted portfolio which resulted in some of our businesses such as Gleeson and Ten Entertainment closing entirely for a period. Stobart was also very hard hit as its principal asset Southend Airport ground to a standstill. Whilst these businesses are now once again operating, it most likely will take a long time before they return to normality and their share prices return to former levels. Against that, it was fortunate that the portfolio has some exposure to life sciences with EKF, Renalytix and Ergomed (which has now been sold) all performing well. Finally, Oryx very significantly outperformed its benchmark again and Odyssian also outperformed, although to a much lesser extent. US portfolio The US portfolio, albeit small, materially underperformed the S&P due to its heavy exposure to banks. unquoted portfolio The investment in Jaguar Holdings a provider of airline catering services had to be written down, although it is pleasing to note that the group remained cash flow positive throughout the period. Sherwood Holdings (Source Bioscience) however benefitted from COVID testing and was written up in anticipation of a public offering which is expected to occur in September. It is also expected that Verici DX will be listed in September with very strong demand already in place from institutions. Finally, there is a possibility that another of the unquoted investments will go public at a very substantial premium to the July valuation although, if this happens, it will be towards the end of the year. Outlook Stock markets, and in particular the United States, have performed extraordinarily well given the damage done to public finances and the economy. As worldwide schemes to protect employment are unwound and unemployment rises, it is hard to be overly optimistic about corporate profits in most industries. We do, however, expect a modest level of corporate activity which might give some underpinning to equities. We did however take the opportunity of the weakness in the market to build new positions in Circassia and Tribal Group, both of which based on end August share prices have performed well since purchase. Finally, Assetco was largely successful in contesting Grant Thornton's appeal so hopefully the Company will receive a substantial cash injection as the lawsuit reaches conclusion and the company returns cash to investors. C H B Mills
14/5/2020
03:11
rambutan2: Prelims released tues: ...Our cash holdings (comprising cash at banks and US treasury bills) fell significantly during the period from approximately GBP122m to GBP82m. This is due to the repurchase of company shares for redemption and a number of new investments which we believe trade at significant discount to fair value. Since the end of the period all world markets have fallen very substantially due to the onset of the COVID-19 virus which has disastrously impacted economic activity. Many of our businesses have either had to shut down or have had operations substantially curtailed. As noted above we have entered this downturn with very substantial liquid resources. Shareholders will already be aware we have tended to invest mainly in companies with strong balance sheets. We are therefore very well placed to support our businesses where appropriate. To date we have helped refinance Ten Entertainment so that it can now withstand a shutdown of fifteen months at a cost of less than GBP1m. We would expect that no more than two or three other investments will require funding with an estimated cost to the Company of no more than GBP5m. Either I or a member of my team have now spoken to every major investment in the Company and Oryx (which also has comparable cash balances) and can confirm that we are confident that our business will survive this very difficult economic downturn. It is however inevitable that corporate activity will be curtailed for some time so that realisations may take longer to occur than was originally anticipated. Notwithstanding this I anticipate that the next few months will present some good opportunities and therefore remain confident that the Company will continue to provide positive returns once a degree of normality is restored. Christopher Mills Chief Executive & Investment Manager 12 May 2020 https://uk.advfn.com/stock-market/london/north-atlantic-smaller-c-NAS/share-news/North-Atlantic-Smlr-Co-Inv-Tst-PLC-Final-Results/82437593 htTps://www.nascit.co.uk
North Atlantic Smaller C... share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
NAS
North Atla..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210305 06:57:56